Skip redundant pieces
Research Institute

Clinical Trials Education Lecture Series


19 February 2004

Investigational New Drug Filing

Bruce F. Kimler, Ph.D.
Professor
Department of Radiation Oncology

 

Main Page for Food and Drug Administration
http://www.fda.gov

Center for Drug Evaluation and Research
http://www.fda.gov/cder/

Drug Applications
http://www.fda.gov/cder/regulatory/applications/default.htm

Investigational New Drug (IND) Application
http://www.fda.gov/cder/regulatory/applications/ind_page_1.htm

          Introduction
          http://www.fda.gov/cder/regulatory/applications/ind_page_1.htm#Introduction

                   Three types of applications

                   Interactive Chart
                   http://www.fda.gov/cder/handbook/ind.htm

                   Pre-IND Consultation Program
                   http://www.fda.gov/cder/ode4/preind/default.htm

                   Content and Format for INDs for Phase I Studies
                   http://www.fda.gov/cder/guidance/phase1.pdf

                   Exemptions of Marketed Drugs for Treatment of Cancer
                   http://www.fda.gov/cder/guidance/6036fnl.pdf

          Information for Clinical Investigators
          http://www.fda.gov/cder/about/smallbiz/clinical_investigator.htm

                   General Information
                   http://www.fda.gov/cder/about/smallbiz/general_info.htm

                   IRBs and Protection of Human Subjects
                   http://www.fda.gov/cder/about/smallbiz/humans.htm

                   Clinical Investigator Inspection
                   http://www.fda.gov/cder/regulatory/investigators/default.htm

                   Regulatory and Compliance Information
                   http://www.fda.gov/cder/about/smallbiz/regs_and_compliance.htm

                   Clinical Investigator Forms

                             Disclosure of Financial Interests
                             http://forms.psc.gov/forms/FDA/FDA-3455.pdf

         FDA Forms
                   http://forms.psc.gov/forms/FDA/fda.html

                   Form 1571
                   http://forms.psc.gov/forms/FDA/1571es.pdf

                   Form 1572
                   http://forms.psc.gov/forms/FDA/FDA-1572.pdf

                   Instructions for 1571 and 1572
                   http://www.fda.gov/cder/forms/1571-1572-help.html

         FAQs on Drug Development
         http://www.fda.gov/cder/about/smallbiz/faq.htm

                   When can a trial start?
                   When is an IND number assigned?
                  Exemption

                   Exemption Request to FDA
                   Sample letter

                   Exemption Letter from FDA
                   Sample letter

                   Submission of an IND Application
                   Sample 1571
                   Sample Application

 

This page last updated: September, 06, 2008